Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?

Autor: Linson, Patrick W ^*, Lee, Andrew K, Doytchinova, Tatiana, Chen, Ming-Hui, Weinstein, Michael H, Richie, Jerome P, D’Amico, Anthony V

Publikováno v: In Urology 2002 59(5):704-708

Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series.

Autor: Juarez JE; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, California., Romero T; Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, California., Mantz CA; 21st Century Oncology, Inc, Fort Meyers, Florida., Pepin A; Department of Radiation Medicine, Georgetown University Hospital, Washington, DC.; Department of Radiation Oncology, George Washington School of Medicine and Health Sciences, Washington, DC., Aghdam N; Department of Radiation Medicine, Georgetown University Hospital, Washington, DC., Suy S; Department of Radiation Medicine, Georgetown University Hospital, Washington, DC., Steinberg ML; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, California., Levin-Epstein RG; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, California., Nickols NG; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, California.; Department of Radiation Oncology, West Los Angeles Veterans Health Administration, Los Angeles, California., Kaplan ID; Department of Radiation Oncology, Beth Israel Deaconess, Boston, Massachusetts., Meier RM; Swedish Radiosurgery Center, Seattle, Washington., Pham HT; Section of Radiation Oncology, Virginia Mason Medical Center, Seattle, Washington., Linson PW; Department of Radiation Oncology, Scripps MD Anderson Cancer Center, San Diego, California., Hong RL; Department of Radiation Oncology, Virginia Hospital Center, Arlington, Virginia., Buyyounouski MK; Department of Radiation Oncology, Stanford University, Stanford, California., Bagshaw HP; Department of Radiation Oncology, Stanford University, Stanford, California., Fuller DB; Division of Genesis Health care Partners Inc, CyberKnife Centers of San Diego Inc, San Diego, California., Katz AJ; Flushing Radiation Oncology Services, New York., Loblaw A; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada., Collins SP; Department of Radiation Medicine, Georgetown University Hospital, Washington, DC., Kishan AU; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, California.; Department of Urology, University of California, Los Angeles, California.

Publikováno v: Advances in radiation oncology [Adv Radiat Oncol] 2021 Aug 28; Vol. 6 (6), pp. 100759. Date of Electronic Publication: 2021 Aug 28 (Print Publication: 2021).